<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82112">
  <stage>Registered</stage>
  <submitdate>12/07/2007</submitdate>
  <approvaldate>24/07/2007</approvaldate>
  <actrnumber>ACTRN12607000389404</actrnumber>
  <trial_identification>
    <studytitle>Efficacy of ultrasound guided Transversus Abdominis Plane (TAP) block following major abdominal surgery: a randomised controlled trial.</studytitle>
    <scientifictitle>women undergo elective caesarean section-Transversus Abdominis Plane (TAP) block on the abdominal wall under ultrasound guidance-conventional postoperative analgesic management-reduce pain medications post operation and improve patient comfort</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>healthy women undergo elective caesarean section, no allergy to the analgesic drug ropivacaine and morphine.</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>
Intervention: patient receive ropivacaine 200mg by the TAP block technique.
All patients will be treated with standardised pain management and post analgesic care after surgery including a Patient Controlled Analgesia (PCA) device which will deliver standard doses of morphine (1mg with a 5 minute lockout) intravenously when patient requires it for pain relief.</interventions>
    <comparator>Control: patients receive injection of normal saline by the TAP block technique.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Morphine requirement by patient </outcome>
      <timepoint>At 24 hours, 48 hours and 5-days period.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Other pain medications and patient satisfaction</outcome>
      <timepoint>At 24h, 48h and 5-days period.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Women undergo elective caesarean section</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Emergency caesarean section, refusal to participate in the study, allergies to any of the drugs used in the study (e.g. morphine or ropivacaine); insufficiency in speaking or reading English.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Randomisation slips will be stored in numbered opaque sealed envelopes and opened only in consented patients prior to surgery</concealment>
    <sequence>Sequence will be computer generated in blocks.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Patients will be blinded from what injection they receive. Only the anaesthetist who performed the procedure knows what the patient received, others including an observer will be blinded and responsible for monitoring patients progress and pain treatment requirements. The data analyst will also be blinded.</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>21/07/2007</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>104</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Department of Anaesthesia, St Vincent's Hospital</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Department of Anaesthesia, St Vincent's Hospital</fundingname>
      <fundingaddress />
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Dr Michael Barrington, St Vincent's Hospital</sponsorname>
      <sponsoraddress />
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The object of this project is to determine how useful an ultrasound guided TAP block is in reducing requirement for pain medications following elective caesarean section.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>St Vincent's Hospital</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Michael Barrington</name>
      <address>c/o Department of Anaesthesia
St Vincents Hospital
Melbourne Fitzroy VIC 3065</address>
      <phone>92882211, 92884257</phone>
      <fax>92884255</fax>
      <email>michael.barrington@svhm.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Michael Barrington</name>
      <address>c/o Department of Anaesthesia
St Vincents Hospital
Melbourne Fitzroy VIC 3065</address>
      <phone>92882211, 92884257</phone>
      <fax>92884255</fax>
      <email>michael.barrington@svhm.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>